USA - NASDAQ:SLXN - KYG1281K1307 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to SLXN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating | 
|---|---|---|---|
| 2025-03-20 | Maxim Group | Maintains | Buy -> Buy | 
| 2024-11-01 | Maxim Group | Initiate | Buy | 
7 analysts have analysed SLXN and the average price target is 24.48 USD. This implies a price increase of 641.82% is expected in the next year compared to the current price of 3.3.
The consensus rating for SILEXION THERAPEUTICS CORP (SLXN) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering SILEXION THERAPEUTICS CORP (SLXN) is 7.